Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Genetics and genomics of prostate cancer.

Dean M, Lou H.

Asian J Androl. 2013 May;15(3):309-13. doi: 10.1038/aja.2013.29. Review.

2.

A covering method for detecting genetic associations between rare variants and common phenotypes.

Bhatia G, Bansal V, Harismendy O, Schork NJ, Topol EJ, Frazer K, Bafna V.

PLoS Comput Biol. 2010 Oct 14;6(10):e1000954. doi: 10.1371/journal.pcbi.1000954.

3.

A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.

Waters KM, Stram DO, Le Marchand L, Klein RJ, Valtonen-André C, Peltola MT, Kolonel LN, Henderson BE, Lilja H, Haiman CA.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2639-46. doi: 10.1158/1055-9965.EPI-10-0427.

4.

Mutation analysis of the MSMB gene in familial prostate cancer.

Kote-Jarai Z, Leongamornlert D, Tymrakiewicz M, Field H, Guy M, Al Olama AA, Morrison J, O'Brien L, Wilkinson R, Hall A, Sawyer E, Muir K, Hamdy F, Donovan J, Neal D, Easton D, Eeles R.

Br J Cancer. 2010 Jan 19;102(2):414-8. doi: 10.1038/sj.bjc.6605485.

5.

Genome-wide association studies in cancer--current and future directions.

Chung CC, Magalhaes WC, Gonzalez-Bosquet J, Chanock SJ.

Carcinogenesis. 2010 Jan;31(1):111-20. doi: 10.1093/carcin/bgp273.

Supplemental Content

Support Center